Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13458)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2014 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Toshikuni N, Tsutsumi M, Arisawa T. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8393-8406 [PMID: 25024597 DOI: 10.3748/wjg.v20.i26.8393] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8393.htm |
| Number | Citing Articles |
| 1 |
Hiral Aghara, Prashsti Chadha, Devangi Zala, Palash Mandal. Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1205821
|
| 2 |
Ashal Ilyas, Yasanandana Supunsiri Wijayasinghe, Ilyas Khan, Nourhan M. El Samaloty, Mohd Adnan, Tanveer Ali Dar, Nitesh Kumar Poddar, Laishram R. Singh, Hemlata Sharma, Shahanavaj Khan. Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.964624
|
| 3 |
Bo Yoon Chang, Hyung Joong Kim, Tae Young Kim, Sung Yeon Kim. Enzyme-Treated Zizania latifolia Extract Protects against Alcohol-Induced Liver Injury by Regulating the NRF2 Pathway. Antioxidants 2021; 10(6): 960 doi: 10.3390/antiox10060960
|
| 4 |
Ying Zhang, Xingzhong Miao, Fang Liu, Honglin Shi, Dexi Chen, Yu Chen, Yingmin Ma, Hongbo Shi. ASPP2 deficiency attenuates lipid accumulation through the PPARγ pathway in alcoholic liver injury. Cell Biology and Toxicology 2024; 40(1) doi: 10.1007/s10565-024-09925-x
|
| 5 |
Lauren Weaver, Abdul-rizaq Hamoud, David E. Stec, Terry D. Hinds. Biliverdin reductase and bilirubin in hepatic disease. American Journal of Physiology-Gastrointestinal and Liver Physiology 2018; 314(6): G668 doi: 10.1152/ajpgi.00026.2018
|
| 6 |
Marica Meroni, Miriam Longo, Raffaela Rametta, Paola Dongiovanni. Genetic and Epigenetic Modifiers of Alcoholic Liver Disease. International Journal of Molecular Sciences 2018; 19(12): 3857 doi: 10.3390/ijms19123857
|
| 7 |
Sumit Sharma, Debashree Kar, Prabal Dweep Khanikar, Akshay Moudgil, Prashant Mishra, Samaresh Das. Hybrid MoSe2/P3HT Transistor for Real-Time Ammonia Sensing in Biofluids. ACS Applied Materials & Interfaces 2024; 16(24): 30648 doi: 10.1021/acsami.4c02352
|
| 8 |
Ali Zarrinpar, Claire M. Faltermeier, Vatche G. Agopian, Bita V. Naini, Michael P. Harlander‐Locke, Fady M. Kaldas, Douglas G. Farmer, Ronald W. Busuttil. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis. Liver International 2019; 39(3): 531 doi: 10.1111/liv.14002
|
| 9 |
Jihye Lim, Hyunji Sang, Ha Il Kim. Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease. JHEP Reports 2023; 5(6): 100721 doi: 10.1016/j.jhepr.2023.100721
|
| 10 |
Morteza Nayebi, Seyed Saeed Seyedian, Seyed Jalal Hashemi, Abazar Parsi, Eskandar Hajiani. Association between high-sensitivity-CRP and liver elastography and cardiac ischemic diseases in patients with fatty liver. Journal of Family Medicine and Primary Care 2022; 11(9): 5495 doi: 10.4103/jfmpc.jfmpc_2223_21
|
| 11 |
Meilan Xue, Yingjie Tian, Yingzhong Sui, Hui Zhao, Haiqi Gao, Hui Liang, Xia Qiu, Zhanyi Sun, Yi Zhang, Yimin Qin. Protective effect of fucoidan against iron overload and ferroptosis-induced liver injury in rats exposed to alcohol. Biomedicine & Pharmacotherapy 2022; 153: 113402 doi: 10.1016/j.biopha.2022.113402
|
| 12 |
Fei Xie, Yifei Song, Yang Yi, Xue Jiang, Shiwen Ma, Chen Ma, Junyu Li, Ziyi Zhanghuang, Mengyu Liu, Pengxiang Zhao, Xuemei Ma. Therapeutic Potential of Molecular Hydrogen in Metabolic Diseases from Bench to Bedside. Pharmaceuticals 2023; 16(4): 541 doi: 10.3390/ph16040541
|
| 13 |
Hassan Mumtaz, Madiha Hameed, Abdul Basit Sangah, Amraha Zubair, Mohammad Hasan. Association between smoking and non-alcoholic fatty liver disease in Southeast Asia. Frontiers in Public Health 2022; 10 doi: 10.3389/fpubh.2022.1008878
|
| 14 |
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions. Life Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
|
| 15 |
Janna C. Nawroth, Debora B. Petropolis, Dimitris V. Manatakis, Tengku Ibrahim Maulana, Gabriel Burchett, Katharina Schlünder, Anke Witt, Abhishek Shukla, Konstantia Kodella, Janey Ronxhi, Gauri Kulkarni, Geraldine Hamilton, Ekihiro Seki, Shelly Lu, Katia C. Karalis. Modeling alcohol-associated liver disease in a human Liver-Chip. Cell Reports 2021; 36(3): 109393 doi: 10.1016/j.celrep.2021.109393
|
| 16 |
Yoosoo Chang, Seungho Ryu, Ki-Chul Sung, Yong Kyun Cho, Eunju Sung, Han-Na Kim, Hyun-Suk Jung, Kyung Eun Yun, Jiin Ahn, Hocheol Shin, Sarah Helen Wild, Christopher D Byrne. Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study. Gut 2019; 68(9): 1667 doi: 10.1136/gutjnl-2018-317666
|
| 17 |
Rongxuan Li, Weiyue Xue, Huiting Wei, Qingqing Fan, Xiang Li, Ye Qiu, Di Cui. Research Progress of Pyroptosis in Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(17): 13065 doi: 10.3390/ijms241713065
|
| 18 |
Nobuyuki Toshikuni, Mutsumi Tsuchishima, Atsushi Fukumura, Tomiyasu Arisawa, Mikihiro Tsutsumi. Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis. Gastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/9127847
|
| 19 |
Rolf Teschke. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opinion on Pharmacotherapy 2018; 19(8): 779 doi: 10.1080/14656566.2018.1465929
|
| 20 |
Piero Portincasa. NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care. Internal and Emergency Medicine 2023; 18(4): 993 doi: 10.1007/s11739-023-03203-0
|
| 21 |
Alejandro Torres‐Hernandez, Wei Wang, Yuri Nikiforov, Karla Tejada, Luisana Torres, Aleksandr Kalabin, Salma Adam, Jingjing Wu, Lu Lu, Ruonan Chen, Aaron Lemmer, Jimmy Camargo, Mautin Hundeyin, Brian Diskin, Berk Aykut, Emma Kurz, Juan A. Kochen Rossi, Mohammed Khan, Miguel Liria, Gustavo Sanchez, Nan Wu, Wenyu Su, Steven Adams, Muhammad Israr Ul Haq, Mohammad Saad Farooq, Varshini Vasudevaraja, Joshua Leinwand, George Miller. γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming. Hepatology 2020; 71(2): 477 doi: 10.1002/hep.30952
|
| 22 |
Massoud Houshmand, Vahide Zeinali, Amirhossein Hosseini, Atena Seifi, Bardia Danaei, Sharareh Kamfar. Investigation of FGF21 mRNA levels and relative mitochondrial DNA copy number levels and their relation in nonalcoholic fatty liver disease: a case-control study. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1203019
|
| 23 |
Laura Valenzuela-Vallejo, Christos S. Mantzoros. Time to transition from a negative nomenclature describing what NAFLD is not, to a novel, pathophysiology-based, umbrella classification of fatty liver disease (FLD). Metabolism 2022; 134: 155246 doi: 10.1016/j.metabol.2022.155246
|
| 24 |
Salvatore Greco, Michele Campigotto, Andrea D’Amuri, Nicolò Fabbri, Angelina Passaro. Dyslipidemia, Cholangitis and Fatty Liver Disease: The Close Underexplored Relationship: A Narrative Review. Journal of Clinical Medicine 2024; 13(9): 2714 doi: 10.3390/jcm13092714
|
| 25 |
Jin-Zhou Zhu, Yi-Ning Dai, Yu-Ming Wang, Qin-Yi Zhou, Chao-Hui Yu, You-Ming Li. Prevalence of Nonalcoholic Fatty Liver Disease and Economy. Digestive Diseases and Sciences 2015; 60(11): 3194 doi: 10.1007/s10620-015-3728-3
|
| 26 |
Victory Okpujie, Opeyemi Tobalesi, Fidelis Uwumiro, Amaka C Ugoh, Elsie O Osiogo, Olawale Abesin, Oluwatobi A Olaomi, Chimaobi O Nwevo, Tosin Ayantoyinbo, Franklin Ejeagha. The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide Study. Cureus 2023; doi: 10.7759/cureus.42964
|
| 27 |
Sumra Nazir, Vera Jankowski, Guzide Bender, Stephen Zewinger, Kerry-Anne Rye, Emiel P.C. van der Vorst. Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!. Advanced Drug Delivery Reviews 2020; 159: 94 doi: 10.1016/j.addr.2020.10.006
|
| 28 |
Perizat Kanabekova, Adina Kadyrova, Gulsim Kulsharova. Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro. Micromachines 2022; 13(3): 428 doi: 10.3390/mi13030428
|
| 29 |
Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, Aki S. Havulinna, Guillaume Méric, Yang Liu, Rohit Loomba, Yoshiki Vázquez-Baeza, Anupriya Tripathi, Liisa M. Valsta, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J. Niiranen. Links between gut microbiome composition and fatty liver disease in a large population sample. Gut Microbes 2021; 13(1) doi: 10.1080/19490976.2021.1888673
|
| 30 |
Taewoo Kim, Dong Hyun Lee, Eun-Kee Park, Sanghun Choi. Deep Learning Techniques for Fatty Liver Using Multi-View Ultrasound Images Scanned by Different Scanners: Development and Validation Study. JMIR Medical Informatics 2021; 9(11): e30066 doi: 10.2196/30066
|
| 31 |
Xiya Li, Zhen Li, Mengmeng Zhang, Guangsen Li, Tingting Yu. Shear wave elastography to evaluate carotid artery elasticity in long‐term drinkers with varying degrees of alcoholic fatty liver disease. Journal of Clinical Ultrasound 2023; 51(4): 696 doi: 10.1002/jcu.23398
|
| 32 |
Jia-Hung Lin, Chi-Huei Lin, Yi-Wei Kuo, Chorng-An Liao, Jui-Fen Chen, Shin-Yu Tsai, Ching-Min Li, Yu-Chieh Hsu, Yen-Yu Huang, Ko-Chiang Hsia, Yao-Tsung Yeh, Hsieh-Hsun Ho, Imad Al Kassaa. Probiotic Lactobacillus fermentum TSF331, Lactobacillus reuteri TSR332, and Lactobacillus plantarum TSP05 improved liver function and uric acid management-A pilot study. PLOS ONE 2024; 19(7): e0307181 doi: 10.1371/journal.pone.0307181
|
| 33 |
Santosh Kumar Behera, Ardhendu Bhusan Praharaj, Gayathri Chalikonda, Gowru Srivani, Namita Mahapatra. Theranostics Approaches to Gastric and Colon Cancer. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 167 doi: 10.1007/978-981-15-2017-4_11
|
| 34 |
Si-Si Jin, Chun-Jing Lin, Xian-Fan Lin, Ju-Zeng Zheng, Hua-Qin Guan. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway. Annals of Hepatology 2022; 27(2): 100584 doi: 10.1016/j.aohep.2021.100584
|
| 35 |
N. V. Mikhaylova, I. L. Petrunko. Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences. Acta Biomedica Scientifica (East Siberian Biomedical Journal) 2019; 4(3): 23 doi: 10.29413/ABS.2019-4.3.3
|
| 36 |
Peter S. Micalos, Sok Cheon Pak, Soo Liang Ooi. Modified Rice Bran Arabinoxylan. 2023; : 135 doi: 10.1007/978-981-19-5735-2_12
|
| 37 |
N. R. Matkovska, N. H. Virstiuk, U. V. Balan, I. O. Kostitska, M. S. Voloshynovych, N. V. Chaplynska, V. T. Rudnyk. CLINICAL AND LABORATORY MANIFESTATIONS OF ALCOHOLIC LIVER DISEASE AT THE CIRRHOSIS STAGE ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON DISEASE COMPENSATION. World of Medicine and Biology 2022; 18(79): 94 doi: 10.26724/2079-8334-2022-1-79-94-98
|
| 38 |
Julian Wangler, Michael Jansky. Evaluation of elevated liver values in primary care - a series of studies on the status quo of care in Germany with special reference to alcoholic liver disease. BMC Primary Care 2022; 23(1) doi: 10.1186/s12875-022-01714-x
|
| 39 |
Silvia Espina, Diego Casas-Deza, Vanesa Bernal-Monterde, Ana Royo-Esteban, Maria Pilar García-Sobreviela, Pilar Calmarza, Ana B. Martinez-Martinez, Jesús Osada, Jose M. Arbones-Mainar. Unraveling the Association of Liver Steatosis and Fibrosis with Vitamin B12: A Cross-Sectional Study. Metabolites 2024; 14(11): 618 doi: 10.3390/metabo14110618
|
| 40 |
Junling Wang, Ping Li, Zhilong Jiang, Qiuhui Yang, Yuqiang Mi, Yonggang Liu, Ruifang Shi, Yonghe Zhou, Jinsheng Wang, Wei Lu, Si Li, Dan Liu. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD. The Korean Journal of Internal Medicine 2016; 31(3): 479 doi: 10.3904/kjim.2015.253
|
| 41 |
J. S. Metcalf, R. A. Dunlop, J. T. Powell, S. A. Banack, P. A. Cox. L-Serine: a Naturally-Occurring Amino Acid with Therapeutic Potential. Neurotoxicity Research 2018; 33(1): 213 doi: 10.1007/s12640-017-9814-x
|
| 42 |
Andrija Matetic, Tahmeed Contractor, Mohamed O. Mohamed, Rahul Bhardwaj, Ashish Aneja, Phyo K. Myint, Mina O. Rakoski, Shelley Zieroth, Timir K. Paul, Mamas A. Mamas. Trends, management and outcomes of acute myocardial infarction in chronic liver disease. International Journal of Clinical Practice 2021; 75(4) doi: 10.1111/ijcp.13841
|
| 43 |
Anca Trifan, Cristina-Maria Muzica, Robert Nastasa, Sebastian Zenovia, Ermina Stratina, Remus Stafie, Adrian Rotaru, Ana-Maria Singeap, Camelia Cojocariu, Catalin Sfarti, Irina Girleanu, Stefan Chiriac, Tudor Cuciureanu, Laura Huiban, Carol Stanciu. High prevalence of liver fibrosis among general population: a Romanian population-based study. Hepatology Communications 2023; 7(2): e0032 doi: 10.1097/HC9.0000000000000032
|
| 44 |
Giovanni Tarantino, Vincenzo Citro. What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?. Lipids in Health and Disease 2024; 23(1) doi: 10.1186/s12944-024-02031-1
|
| 45 |
Hitoshi Maeda, Yu Ishima, Junji Saruwatari, Yuki Mizuta, Yuki Minayoshi, Shota Ichimizu, Hiroki Yanagisawa, Taisei Nagasaki, Kengo Yasuda, Shun Oshiro, Manabu Taura, Matthew J. McConnell, Kentaro Oniki, Kayoko Sonoda, Tomohiko Wakayama, Manabu Kinoshita, Tsuyoshi Shuto, Hirofumi Kai, Motohiko Tanaka, Yutaka Sasaki, Yasuko Iwakiri, Masaki Otagiri, Hiroshi Watanabe, Toru Maruyama. Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH. Journal of Controlled Release 2022; 341: 457 doi: 10.1016/j.jconrel.2021.11.039
|
| 46 |
Eun-Hee Nah, Seon Cho, Suyoung Kim, Jieun Chu, Eunjoo Kwon, Han-Ik Cho. Prevalence of liver fibrosis and associated risk factors in the Korean general population: a retrospective cross-sectional study. BMJ Open 2021; 11(3): e046529 doi: 10.1136/bmjopen-2020-046529
|
| 47 |
Jian Ju, Mozaniel Santana de Oliveira, Yu Qiao. Cinnamon: A Medicinal Plant and A Functional Food Systems. Food Bioactive Ingredients 2023; : 231 doi: 10.1007/978-3-031-33505-1_16
|
| 48 |
Ana Murillo, Siqi Hu, Maria Fernandez. Zeaxanthin: Metabolism, Properties, and Antioxidant Protection of Eyes, Heart, Liver, and Skin. Antioxidants 2019; 8(9): 390 doi: 10.3390/antiox8090390
|
| 49 |
Hideki Fujii, Naoki Nishimoto, Seiko Yamaguchi, Osamu Kurai, Masato Miyano, Wataru Ueda, Hiroko Oba, Tetsuya Aoki, Norifumi Kawada, Kiyotaka Okawa. The Alcohol Use Disorders Identification Test for Consumption (AUDIT-C) is more useful than pre-existing laboratory tests for predicting hazardous drinking: a cross-sectional study. BMC Public Health 2016; 16(1) doi: 10.1186/s12889-016-3053-6
|
| 50 |
Melynda S. Coker, Kaylee R. Ladd, Jimin Kim, Carl J. Murphy, Ryan DeCort, Bradley R. Newcomer, Robert R. Wolfe, Robert H. Coker. Essential Amino Acid Supplement Lowers Intrahepatic Lipid despite Excess Alcohol Consumption. Nutrients 2020; 12(1): 254 doi: 10.3390/nu12010254
|
| 51 |
Alba Meneses, José Manuel Santabárbara, Juan Antonio Romero, Roberto Aliaga, Alicia María Maceira, David Moratal. Determination of Non-Invasive Biomarkers for the Assessment of Fibrosis, Steatosis and Hepatic Iron Overload by MR Image Analysis. A Pilot Study. Diagnostics 2021; 11(7): 1178 doi: 10.3390/diagnostics11071178
|
| 52 |
Yuanqiang Ma, Gyurim Lee, Su-Young Heo, Yoon-Seok Roh. Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease. Antioxidants 2021; 11(1): 91 doi: 10.3390/antiox11010091
|
| 53 |
Szu-Yi Liu, I-Ting Tsai, Yin-Chou Hsu. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives. International Journal of Molecular Sciences 2021; 22(10): 5170 doi: 10.3390/ijms22105170
|
| 54 |
Hyeong-Geug Kim, Jing-Hua Wang, Hyo-Seon Kim, Jin-Seok Lee, Hwi-Jin Im, Sung-Bae Lee, Dong-soo Lee, Gang-Min Hur, Chang-Gue Son. Animal Evidence for Synergistic Induction of Hepatic Injury by Dietary Fat and Alcohol Consumption and Its Potential Mechanisms. Journal of Personalized Medicine 2021; 11(4): 287 doi: 10.3390/jpm11040287
|
| 55 |
Madalina Andreea Robea, Ioana-Miruna Balmus, Irina Girleanu, Laura Huiban, Cristina Muzica, Alin Ciobica, Carol Stanciu, Carmen Diana Cimpoesu, Anca Trifan. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance. Medicina 2023; 59(9): 1614 doi: 10.3390/medicina59091614
|
| 56 |
Sumi Sung, Jieun Kim, Youngmi Jung. Liver-Derived Exosomes and Their Implications in Liver Pathobiology. International Journal of Molecular Sciences 2018; 19(12): 3715 doi: 10.3390/ijms19123715
|
| 57 |
Savneet Kaur, Rashi Sehgal, Saggere M. Shastry, Geoffrey McCaughan, Helen M. McGuire, Barbara Fazekas St de Groth, Shiv Sarin, Nirupma Trehanpati, Devanshi Seth. Circulating Endothelial Progenitor Cells Present an Inflammatory Phenotype and Function in Patients With Alcoholic Liver Cirrhosis. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00556
|
| 58 |
Yoosoo Chang, Yong Kyun Cho, Juhee Cho, Hyun-Suk Jung, Kyung Eun Yun, Jiin Ahn, Chong Il Sohn, Hocheol Shin, Seungho Ryu. Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study. American Journal of Gastroenterology 2019; 114(4): 620 doi: 10.14309/ajg.0000000000000074
|
| 59 |
Bo Li, Shan-Shan Lei, Jie Su, Xia-Miao Cai, Hao Xu, Xinglishang He, Ye-Hui Chen, Hai-Xia Lu, He Li, Liu-Qing Qian, Xiang Zheng, Gui-Yuan Lv, Su-Hong Chen. Alcohol Induces More Severe Fatty Liver Disease by Influencing Cholesterol Metabolism. Evidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/7095684
|
| 60 |
Stephen Malnick, Yaakov Maor. The Interplay between Alcoholic Liver Disease, Obesity, and the Metabolic Syndrome. Visceral Medicine 2020; 36(3): 198 doi: 10.1159/000507233
|
| 61 |
Vetriselvan Subramaniyan, Natasha Sura Anak Lubau, Nobendu Mukerjee, Vinoth Kumarasamy. Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potential. Toxicology Reports 2023; 11: 355 doi: 10.1016/j.toxrep.2023.10.005
|
| 62 |
J. Jadzic, P. Milovanovic, N. Tomanovic, V. Zivkovic, D. Djukic, S. Nikolic, M. Djuric, D. Djonic. Micro-scale vertebral features in postmenopausal women with alcohol-associated and metabolic-associated fatty liver disease: ex vivo bone quality analyses. Journal of Endocrinological Investigation 2023; 47(1): 131 doi: 10.1007/s40618-023-02130-3
|
| 63 |
Hyunna Jung, Sohyeon You, Soo-Im Choi, Chang-Ho Kang, Gun-Hee Kim. Levilactobacillus brevis MG5311 Alleviates Ethanol-Induced Liver Injury by Suppressing Hepatic Oxidative Stress in C57BL/6 Mice. Microorganisms 2022; 10(12): 2488 doi: 10.3390/microorganisms10122488
|
| 64 |
Zehra N. Kocas-Kilicarslan, Zeliha Cetin, Lanuza A.P. Faccioli, Takashi Motomura, Sriram Amirneni, Ricardo Diaz-Aragon, Rodrigo M. Florentino, Yiyue Sun, Iris Pla-Palacin, Mengying Xia, Mark T. Miedel, Takeshi Kurihara, Zhiping Hu, Alina Ostrowska, Zi Wang, Robert Constantine, Albert Li, D. Lansing Taylor, Jaideep Behari, Alejandro Soto-Gutierrez, Edgar N. Tafaleng. Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver Disease. Gastro Hep Advances 2024; 3(1): 67 doi: 10.1016/j.gastha.2023.09.011
|
| 65 |
Sowbhikh Krishnan M, Sudha R. A STUDY OF NONALCOHOLIC FATTY LIVER DISEASE AND FATTY LIVER INDEX IN TYPE 2 DIABETES MELLITUS PATIENTS. Journal of Evidence Based Medicine and Healthcare 2016; 3(57): 3001 doi: 10.18410/jebmh/2016/654
|
| 66 |
Sumit Sharma, Akshay Moudgil, Sanjay Singh, Samaresh Das, Prashant Mishra. Highly Sensitive Tungsten Oxide Thin Film‐Based Field‐Effect Transistor for Real‐Time Monitoring of Dissolved Ammonia in Human Plasma. Advanced Materials Interfaces 2022; 9(19) doi: 10.1002/admi.202200647
|
| 67 |
Abdel Aziz Shaheen, Gilaad G. Kaplan, Keith A. Sharkey, Brendan Cord Lethebe, Mark G. Swain. Impact of major depression and antidepressant use on alcoholic and non‐alcoholic fatty liver disease: A population‐based study. Liver International 2021; 41(10): 2308 doi: 10.1111/liv.14973
|
| 68 |
Anne Caroline Alves Vieira, Fabrícia de Souza Ferreira, Januse Míllia Dantas de Araújo, Larissa Maria Gomes Dutra, Kamila Sabino Batista, Angela Maria Tribuzy de Magalhães Cordeiro, Jailane de Souza Aquino. Exploring the Potential Hepatoprotective Properties of Cactus (Cactaceae) in Liver Health and Disease Management: A Brief Review. Livers 2024; 4(2): 287 doi: 10.3390/livers4020021
|
| 69 |
L. V. Tarasova, V. N. Diomidova, N. V. Tolmacheva, Yu. V. Tsyganova, A. L. Ivanova, J. V. Maslova, E. V. Barsukova. Correlation of secreted frizzled related protein-4 adipokin expression and expression of fatty liver changes under the conditions of a chronic experiment. Experimental and Clinical Gastroenterology 2021; 1(5): 44 doi: 10.31146/1682-8658-ecg-189-5-44-48
|
| 70 |
Poliana C. Marinello, Paola S. Cella, Mayra T.J. Testa, Phillipe B. Guirro, Walison Augusto da Silva Brito, Camila S. Padilha, Alessandra L. Cecchini, Robin P. da Silva, José Alberto R. Duarte, Rafael Deminice. Creatine supplementation protects against diet-induced non-alcoholic fatty liver but exacerbates alcoholic fatty liver. Life Sciences 2022; 310: 121064 doi: 10.1016/j.lfs.2022.121064
|
| 71 |
Kamila Misiakiewicz-Has, Dominika Maciejewska-Markiewicz, Sylwia Rzeszotek, Anna Pilutin, Agnieszka Kolasa, Paweł Szumilas, Ewa Stachowska, Barbara Wiszniewska. The Obscure Effect of Tribulus terrestris Saponins Plus Inulin on Liver Morphology, Liver Fatty Acids, Plasma Glucose, and Lipid Profile in SD Rats with and without Induced Type 2 Diabetes Mellitus. International Journal of Molecular Sciences 2021; 22(16): 8680 doi: 10.3390/ijms22168680
|
| 72 |
Swadha Anand, Sharmila S. Mande. Host-microbiome interactions: Gut-Liver axis and its connection with other organs. npj Biofilms and Microbiomes 2022; 8(1) doi: 10.1038/s41522-022-00352-6
|
| 73 |
Seung Yeon Lee, Donghyun Kim, Seung Hwan Lee, Jong Hwan Sung. Microtechnology-based in vitro models: Mimicking liver function and pathophysiology. APL Bioengineering 2021; 5(4) doi: 10.1063/5.0061896
|
| 74 |
Xi Chen, Xin-Rui Tan, Shi-Jun Li, Xing-Xing Zhang. LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease. Life Sciences 2019; 235: 116829 doi: 10.1016/j.lfs.2019.116829
|
| 75 |
Katharina Staufer, Michel Yegles. Biomarkers for detection of alcohol consumption in liver transplantation. World Journal of Gastroenterology 2016; 22(14): 3725-3734 doi: 10.3748/wjg.v22.i14.3725
|
| 76 |
Claudia Filozof, Barry J. Goldstein, Richard N. Williams, Arun Sanyal. Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. Drugs 2015; 75(12): 1373 doi: 10.1007/s40265-015-0437-3
|
| 77 |
Makoto YAMAMOTO, Takayuki OBATA, Riwa KISHIMOTO, Moyoko TOMIYASU, Akio SAKAMOTO. Advances in MRI Fat Quantitation and the Dixon Method. Japanese Journal of Magnetic Resonance in Medicine 2024; 44(2): 43 doi: 10.2463/jjmrm.2023-1800
|
| 78 |
Jillian Price, Carey Escheik, Ali Weinstein, Patrice Winter, Lynn Gerber, Zobair Younossi. Abnormal cardiac and metabolic measures correlate significantly with lower performance and activity in overweight chronic liver disease. The Journal of Clinical Hypertension 2020; 22(10): 1915 doi: 10.1111/jch.13938
|
| 79 |
Madushika M. Wimalarathne, Quiana C. Wilkerson-Vidal, Emily C. Hunt, Sharifa T. Love-Rutledge. The case for FAT10 as a novel target in fatty liver diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.972320
|
| 80 |
Tyler J. Reed, Danielle D'Ambrosio, Barbara E.C. Knollmann-Ritschel. Educational Case: Evaluating a patient with cirrhosis. Academic Pathology 2022; 9(1): 100031 doi: 10.1016/j.acpath.2022.100031
|
| 81 |
Karthik Shree Harini, Devaraj Ezhilarasan. Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases. Hepatobiliary & Pancreatic Diseases International 2023; 22(4): 333 doi: 10.1016/j.hbpd.2022.10.003
|
| 82 |
Jer-Hwa Hsu, I-Chia Chien, Ching-Heng Lin. Increased risk of chronic liver disease in patients with major depressive disorder: A population-based study. Journal of Affective Disorders 2019; 251: 180 doi: 10.1016/j.jad.2019.03.070
|
| 83 |
Chien-Chao Chiu, Yung-Hao Ching, Yen-Peng Li, Ju-Yun Liu, Yen-Te Huang, Yi-Wen Huang, Sien-Sing Yang, Wen-Ching Huang, Hsiao-Li Chuang. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. Nutrients 2017; 9(11): 1220 doi: 10.3390/nu9111220
|
| 84 |
Hye-Kyung Chung, Ji Sun Nam, Mi-Yeon Lee, Yong-Bum Kim, Yu-Sam Won, Won-Jun Song, Young-Hwan Kim, Chul Woo Ahn, Ki-Chul Sung. The increased amount of coffee consumption lowers the incidence of fatty liver disease in Korean men. Nutrition, Metabolism and Cardiovascular Diseases 2020; 30(10): 1653 doi: 10.1016/j.numecd.2020.05.026
|
| 85 |
Tie-Ning Zhang, Wei Wang, Ni Yang, Xin-Mei Huang, Chun-Feng Liu. Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research Progress. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00457
|
| 86 |
Suryakant Niture, Maxwell A. Gyamfi, Minghui Lin, Uchechukwu Chimeh, Xialan Dong, Weifan Zheng, John Moore, Deepak Kumar. TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation. Cell Death & Disease 2020; 11(3) doi: 10.1038/s41419-020-2369-4
|
| 87 |
Mrigya Babuta, Caroline Morel, Marcelle de Carvalho Ribeiro, Charles Calenda, Martí Ortega-Ribera, Prashanth Thevkar Nagesh, Christopher Copeland, Yuan Zhuang, Yanbo Wang, Yeonhee Cho, Radhika Joshi, Viliam Brezani, Danielle Hawryluk, Aditi Ashish Datta, Jeeval Mehta, Imad Nasser, Gyongyi Szabo. Neutrophil extracellular traps activate hepatic stellate cells and monocytes via NLRP3 sensing in alcohol-induced acceleration of MASH fibrosis. Gut 2024; 73(11): 1854 doi: 10.1136/gutjnl-2023-331447
|
| 88 |
Parcival Maissan, Eva Mooij, Matteo Barberis. Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review. Biology 2021; 10(3): 194 doi: 10.3390/biology10030194
|
| 89 |
Zeinab Ghorbani, Masoomeh Hajizadeh, Azita Hekmatdoost. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence. Hepatobiliary & Pancreatic Diseases International 2016; 15(4): 348 doi: 10.1016/S1499-3872(16)60096-6
|
| 90 |
Yoosoo Chang, Juhee Cho, Yong Kyun Cho, Ara Cho, Yun Soo Hong, Di Zhao, Jiin Ahn, Chong Il Sohn, Hocheol Shin, Eliseo Guallar, Seungho Ryu. Alcoholic and Nonalcoholic Fatty Liver Disease and Incident Hospitalization for Liver and Cardiovascular Diseases. Clinical Gastroenterology and Hepatology 2020; 18(1): 205 doi: 10.1016/j.cgh.2019.05.004
|
| 91 |
Julian Wangler, Michael Jansky. Diagnostik erhöhter Leberwerte in der Primärversorgung – Befunde einer Studienreihe aus haus- und fachärztlicher Perspektive. Zeitschrift für Gastroenterologie 2023; 61(04): 381 doi: 10.1055/a-1852-9822
|
| 92 |
Lingchong Liu, Yu Wang, Jing Zhang, Chao Wang, Youbao Li, Weichang Dai, Chunhong Piao, Junmei Liu, Hansong Yu, Xia Li, Yuhua Wang, Jingsheng Liu. Probiotics in treating with alcoholic liver disease and nonalcoholic fatty liver disease. Food Reviews International 2023; 39(5): 2723 doi: 10.1080/87559129.2021.1967380
|
| 93 |
Hyun Jin Jung, Kyohee Cho, Sun Yeou Kim, Je Kyung Seong, Seung Hyun Oh. Ethanol extract of Pharbitis nil ameliorates liver fibrosis through regulation of the TGFβ1-SMAD2/3 pathway. Journal of Ethnopharmacology 2022; 294: 115370 doi: 10.1016/j.jep.2022.115370
|
| 94 |
Shivani Gandhi, Reetika Menia, Ishani Gupta, Surbhi Mahajan. Unlocking the Mysteries of Death - New Perspectives for Post-mortem Examination. 2023; doi: 10.5772/intechopen.1002066
|
| 95 |
Mohamed Diwan M. AbdulHameed, Venkat R. Pannala, Anders Wallqvist. Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.01007
|
| 96 |
Alexandra Manchel, Radhakrishnan Mahadevan, Ramon Bataller, Jan B. Hoek, Rajanikanth Vadigepalli. Genome-Scale Metabolic Modeling Reveals Sequential Dysregulation of Glutathione Metabolism in Livers from Patients with Alcoholic Hepatitis. Metabolites 2022; 12(12): 1157 doi: 10.3390/metabo12121157
|
| 97 |
Joy Ito, Hector Lemus, Tianying Wu. Serum Phosphorus, Serum Bicarbonate, and Renal Function in Relation to Liver CYP1A2 Activity. Diagnostics 2023; 13(18): 2996 doi: 10.3390/diagnostics13182996
|
| 98 |
Jin-Zhou Zhu, Qin-Yi Zhou, Yu-Ming Wang, Yi-Ning Dai, Jiang Zhu, Chao-Hui Yu, You-Ming Li. Prevalence of fatty liver disease and the economy in China: A systematic review. World Journal of Gastroenterology 2015; 21(18): 5695-5706 doi: 10.3748/wjg.v21.i18.5695
|
| 99 |
Caroline E Geisler, Benjamin J Renquist. Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. Journal of Endocrinology 2017; 234(1): R1 doi: 10.1530/JOE-16-0513
|
| 100 |
Ram B. Jain, Alan Ducatman. Selective Associations of Recent Low Concentrations of Perfluoroalkyl Substances With Liver Function Biomarkers. Journal of Occupational & Environmental Medicine 2019; 61(4): 293 doi: 10.1097/JOM.0000000000001532
|
| 101 |
Chiao-Wei Lin, Ting-Wei Huang, Yu-Ju Peng, Yuan-Yu Lin, Harry John Mersmann, Shih-Torng Ding. A novel chicken model of fatty liver disease induced by high cholesterol and low choline diets. Poultry Science 2021; 100(3): 100869 doi: 10.1016/j.psj.2020.11.046
|
| 102 |
Sedralmontaha Istanbuly, Andrija Matetic, Mohamed O. Mohamed, Sidakpal Panaich, Poonam Velagapudi, Islam Y. Elgendy, Timir K Paul, Mohamad Alkhouli, Mamas A. Mamas. Comparison of Outcomes of Patients With Versus Without Chronic Liver Disease Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology 2021; 156: 32 doi: 10.1016/j.amjcard.2021.06.044
|
| 103 |
Aleksandra Hliwa, Adriana Mika, Maciej Sledzinski, Dariusz Laski, Bruno Ramos-Molina, Tomasz Sledzinski. Changes in the Serum Fatty Acid Profile After Anhepatic Phase of Orthotopic Liver Transplantation Procedure. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.817987
|
| 104 |
Ram B. Jain. Concentration of selected liver enzymes across the stages of glomerular function: the associations with PFOA and PFOS. Heliyon 2019; 5(7): e02168 doi: 10.1016/j.heliyon.2019.e02168
|